Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Insulin signaling in health and disease
AR Saltiel - The Journal of clinical investigation, 2021 - jci.org
The molecular mechanisms of cellular insulin action have been the focus of much
investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in …
investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in …
Akt in cancer: Mediator and more
Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling
pathway. The Akt can be activated by a wide range of growth signals and the biochemical …
pathway. The Akt can be activated by a wide range of growth signals and the biochemical …
mTOR: Role in cancer, metastasis and drug resistance
AK Murugan - Seminars in cancer biology, 2019 - Elsevier
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that gets inputs from
the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of …
the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of …
Signaling pathways and therapeutic approaches in glioblastoma multiforme
M Khabibov, A Garifullin… - International …, 2022 - spandidos-publications.com
Glioblastoma multiforme (GBM) is the most aggressive type of primary brain tumor and is
associated with a poor clinical prognosis. Despite the progress in the understanding of the …
associated with a poor clinical prognosis. Despite the progress in the understanding of the …
Targeting AKT for cancer therapy
M Shariati, F Meric-Bernstam - Expert opinion on investigational …, 2019 - Taylor & Francis
Introduction: Targeted therapies in cancer aim to inhibit specific molecular targets
responsible for enhanced tumor growth. AKT/PKB (protein kinase B) is a serine threonine …
responsible for enhanced tumor growth. AKT/PKB (protein kinase B) is a serine threonine …
Selective targeting of TNF receptors as a novel therapeutic approach
Tumor necrosis factor (TNF) is a central regulator of immunity. Due to its dominant pro-
inflammatory effects, drugs that neutralize TNF were developed and are clinically used to …
inflammatory effects, drugs that neutralize TNF were developed and are clinically used to …
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Diabetes mellitus-related cardiomyopathy (DMCMP) was originally described as a dilated
phenotype with eccentric left ventricular (LV) remodelling and systolic LV dysfunction …
phenotype with eccentric left ventricular (LV) remodelling and systolic LV dysfunction …
Phosphoinositides: tiny lipids with giant impact on cell regulation
T Balla - Physiological reviews, 2013 - journals.physiology.org
Phosphoinositides (PIs) make up only a small fraction of cellular phospholipids, yet they
control almost all aspects of a cell's life and death. These lipids gained tremendous research …
control almost all aspects of a cell's life and death. These lipids gained tremendous research …
mTOR signaling at a glance
The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular
and extracellular signals and serves as a central regulator of cell metabolism, growth …
and extracellular signals and serves as a central regulator of cell metabolism, growth …
Free radicals and antioxidants in normal physiological functions and human disease
Reactive oxygen species (ROS) and reactive nitrogen species (RNS, eg nitric oxide, NO) are
well recognised for playing a dual role as both deleterious and beneficial species. ROS and …
well recognised for playing a dual role as both deleterious and beneficial species. ROS and …